Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
机构信息
The Lancet, London EC2Y 5AS, UK.
出版信息
Lancet. 2020 Jun 13;395(10240):e102. doi: 10.1016/S0140-6736(20)31290-3. Epub 2020 Jun 3.
Abstract
摘要
相似文献
1
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.关注声明：羟氯喹啉或氯喹啉联合或不联合大环内酯类药物治疗COVID-19：一项多国注册分析
Lancet. 2020 Jun 13;395(10240):e102. doi: 10.1016/S0140-6736(20)31290-3. Epub 2020 Jun 3.
2
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤稿——羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册研究分析
Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.
3
Chloroquine and COVID-19: Should We Care about Ototoxicity?氯喹与2019冠状病毒病：我们应该关注耳毒性吗？
Int Arch Otorhinolaryngol. 2020 Jul;24(3):e359-e363. doi: 10.1055/s-0040-1714142. Epub 2020 Jul 31.
4
[Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].[羟氯喹和氯喹治疗新冠病毒病：无有效性证据]
Ned Tijdschr Geneeskd. 2020 Jun 2;164:D5141.
5
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?新型冠状病毒肺炎与氯喹/羟氯喹：是否存在眼科方面的问题？
Am J Ophthalmol. 2020 May;213:A3-A4. doi: 10.1016/j.ajo.2020.03.028. Epub 2020 Mar 25.
6
Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.羟氯喹/氯喹治疗 COVID-19 的影响：一枚硬币的两面。
J Interferon Cytokine Res. 2020 Oct;40(10):469-471. doi: 10.1089/jir.2020.0105. Epub 2020 Sep 1.
7
Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.将知名药物重新用于抗病毒治疗：羟氯喹和氯喹——从 HIV-1 感染到 COVID-19。
Expert Rev Anti Infect Ther. 2020 Nov;18(11):1119-1133. doi: 10.1080/14787210.2020.1792291. Epub 2020 Jul 13.
8
COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?2019冠状病毒病与氯喹/羟氯喹：是否存在眼科方面的问题？
Am J Ophthalmol. 2020 Aug;216:A1-A2. doi: 10.1016/j.ajo.2020.03.029. Epub 2020 May 8.
引用本文的文献
1
Misconduct in science and medicine.科学与医学领域的不当行为。
EFORT Open Rev. 2025 Jul 1;10(7):439-444. doi: 10.1530/EOR-2025-0126.
2
Transparency in the secondary use of health data: assessing the status quo of guidance and best practices.健康数据二次使用中的透明度：评估指南和最佳实践的现状
R Soc Open Sci. 2025 Mar 26;12(3):241364. doi: 10.1098/rsos.241364. eCollection 2025 Mar.
3
Predicting hospital length of stay using machine learning on a large open health dataset.利用大型开源健康数据集的机器学习预测住院时间。
BMC Health Serv Res. 2024 Jul 29;24(1):860. doi: 10.1186/s12913-024-11238-y.
4
Inaugural Lifestyle Medicine Editorial: Lifestyle medicine in the time of COVID-19.生活方式医学创刊社论：新冠疫情时代的生活方式医学
Lifestyle Med (Hoboken). 2020 Jul;1(1):e1. doi: 10.1002/lim2.1. Epub 2020 Jun 11.
5
Chloroquine chaos and COVID-19: Smart delivery perspectives through pH sensitive polymers/micelles and ZnO nanoparticles.氯喹之乱与新冠肺炎：通过pH敏感聚合物/胶束和氧化锌纳米颗粒实现智能递送的前景
Arab J Chem. 2023 Feb;16(2):104468. doi: 10.1016/j.arabjc.2022.104468. Epub 2022 Nov 30.
6
Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club.#IDJClub 对基于 Twitter 的传染病期刊俱乐部的教育影响。
Clin Infect Dis. 2022 May 15;74(Suppl_3):S244-S250. doi: 10.1093/cid/ciac108.
7
Halting 'research waste'.遏制“研究浪费”。
Br Dent J. 2021 Sep;231(6):317-318. doi: 10.1038/s41415-021-3488-8.
8
Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan.药物获益-风险评估中使用真实世界证据在日本的监管决策方面的接受和使用情况的演变
Clin Pharmacol Ther. 2022 Jan;111(1):35-43. doi: 10.1002/cpt.2410. Epub 2021 Sep 18.
9
Clinical characteristics of COVID-19 patients evaluated in the emergency department: A retrospective cohort study of 801 cases.急诊科评估的COVID-19患者的临床特征：一项对801例病例的回顾性队列研究。
J Am Coll Emerg Physicians Open. 2021 Aug 23;2(4):e12538. doi: 10.1002/emp2.12538. eCollection 2021 Aug.
10
Is rapid scientific publication also high quality? Bibliometric analysis of highly disseminated COVID-19 research papers.快速的科学发表就意味着高质量吗？对广泛传播的新冠病毒研究论文的文献计量分析。
Learn Publ. 2021 Oct;34(4):568-577. doi: 10.1002/leap.1403. Epub 2021 Jun 1.
本文引用的文献
1
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤回：羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册分析
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
Zotero 插件